We found that PEGylation does not make the differencewhen the mucus barrier properties are dominated by pathology-associatedproteins, such as the gel-forming mucins MUC5AC and MUC5B (i.e., sputumfrom cystic fibrosis patients). This evidence concerns the gene MUC5AC and cystic fibrosis.